This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

GSK, 31 South Korean pharma companies, distributors fined for bid rigging on vaccine procurement

( July 20, 2023, 03:00 GMT | Official Statement) -- MLex Summary: GlaxoSmithKline and 31 other South Korean pharmaceutical companies and vaccine distributors were hit with a combined fine of 40.9 billion won ($32 million) and corrective orders for rigging bids in the South Korean government’s vaccine procurement over a period of six years. The Korea Fair Trade Commission found that the pharmaceutical companies and distributors had colluded to designate the winning bidder and share bidding prices in 170 bidding processes from 2013 to 2019 for essential vaccines, including those for influenza, tuberculosis, tetanus, cervical cancer and pneumococcal diseases. The statement, in Korean, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections